RUNX2 inhibitor CADD522 improves bone microarchitecture and lipid metabolism in post-menopausal bone loss

More on Osteoporosis

• Osteoporosis therapies affect bone cell spaces differently in mice

  bioRxiv · 6 Oct 2026

  

• Mifepristone improved bone formation in mice with bone loss

  Journal of Pharmaceutical Analysis · 6 Oct 2026

  

• Targeting a cell regulator reduced bone loss in mice

  Nature Communications · 7 Oct 2026

  

• Chronic stress worsened bone loss in mice after ovary removal

  Journal of Cellular Biochemistry · 6 Oct 2026